m14skmix | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Kow%2C_Chia_Siang%3B_Hasan%2C_Syed_Shahzad>
?:doi	10.1007/s00296-020-04715-0
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s00296-020-04715-0>
?:journal	Rheumatol_Int
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/dee89a1fb970f67c002d7201b822e469d2199e6b.json
?:pmc_json_files	document_parses/pmc_json/PMC7548404.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7548404>
?:pmid	<https://research.tib.eu/covid-19/entity/33044704.0>
?:pmid	33044704.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/dee89a1fb970f67c002d7201b822e469d2199e6b>
?:source	Medline; PMC
?:title	Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-12

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/m14skmix>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/m14skmix>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all